HTWR


Bull of the Day: Canaccord Raises Price Target for HeartWare International Inc (HTWR)

Shares of HeartWare International Inc (NASDAQ:HTWR) jumped over 90% today, following the news that the heart-failure device maker agreed to be bought by Medtronic PLC (NYSE:MDT) …

Canaccord Maintains Buy On Thoratec Following The Launch Of HeartMate III Trial

In a research note published Friday, Canaccord analyst Jason Mills maintained a Buy rating on Thoratec Corp. (THOR) with a price target of $37.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts